Highlights – 2nd Quarter 2013
- Organic sales growth of 3.3% despite more difficult markets
- Positive effects of efficiency program “Fit for 2018” well on track
- Margin expansion in nearly all divisions
- Increase in EBITDA pre one-time items of 10.7% to € 826 million
- EPS pre one-time items lifted by 17.7% to € 2.26
- Continuous net financial debt reduction to € 1.3 billion at the end of the quarter
- Guidance for 2013 confirmed despite adverse currency effects: EBITDA pre one-time items ~€ 3.1 to € 3.2 billion
|
Merck Group | Key figures | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million |
Q2 – 2013 |
Q2 – 2012 |
Change |
Jan.–June 2013 |
Jan.–June 2012 |
Change |
|
Total revenues |
2,841.1 |
2,852.1 |
–0.4% |
5,601.6 |
5,497.1 |
1.9% |
|
Sales |
2,743.9 |
2,743.1 |
– |
5,404.3 |
5,307.0 |
1.8% |
|
Operating result (EBIT) |
465.4 |
23.2 |
n.m. |
864.8 |
333.8 |
159.1% |
|
Margin (% of sales) |
17.0% |
0.8% |
|
16.0% |
6.3% |
|
|
EBITDA |
793.1 |
375.0 |
111.5% |
1,546.9 |
1,028.3 |
50.4% |
|
Margin (% of sales) |
28.9% |
13.7% |
|
28.6% |
19.4% |
|
|
EBITDA pre one-time items |
826.4 |
746.6 |
10.7% |
1,627.5 |
1,420.9 |
14.5% |
|
Margin (% of sales) |
30.1% |
27.2% |
|
30.1% |
26.8% |
|
|
EPS pre one-time items (€) |
2.26 |
1.92 |
17.7% |
4.37 |
3.58 |
22.1% |
|
Free cash flow |
549.6 |
625.7 |
–12.1% |
988.2 |
1,045.4 |
–5.5% |
